Neurocrine Biosciences, Inc.

NasdaqGS:NBIX 株式レポート

時価総額:US$13.7b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Neurocrine Biosciences マネジメント

マネジメント 基準チェック /34

Neurocrine Biosciences'の CEO はKevin Gormanで、 Jan2008年に任命され、 の在任期間は 16.42年です。 の年間総報酬は$ 15.75Mで、 6%給与と94%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.51%を直接所有しており、その価値は$ 68.52M 。経営陣と取締役会の平均在任期間はそれぞれ6.6年と11.5年です。

主要情報

Kevin Gorman

最高経営責任者

US$15.8m

報酬総額

CEO給与比率6.0%
CEO在任期間16.4yrs
CEOの所有権0.5%
経営陣の平均在職期間6.6yrs
取締役会の平均在任期間11.5yrs

経営陣の近況

Recent updates

Shareholders Can Be Confident That Neurocrine Biosciences' (NASDAQ:NBIX) Earnings Are High Quality

May 08
Shareholders Can Be Confident That Neurocrine Biosciences' (NASDAQ:NBIX) Earnings Are High Quality

Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Price In Tune With Earnings

Apr 27
Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Price In Tune With Earnings

Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data

Apr 25

Neurocrine Biosciences (NASDAQ:NBIX) Seems To Use Debt Rather Sparingly

Mar 31
Neurocrine Biosciences (NASDAQ:NBIX) Seems To Use Debt Rather Sparingly

Neurocrine Biosciences Heads Into A Catalyst-Rich 2024 With Additional Upside

Feb 11

Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Price In Tune With Earnings

Jan 07
Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Price In Tune With Earnings

Neurocrine Biosciences (NASDAQ:NBIX) Could Easily Take On More Debt

Dec 11
Neurocrine Biosciences (NASDAQ:NBIX) Could Easily Take On More Debt

Does Neurocrine Biosciences (NASDAQ:NBIX) Have A Healthy Balance Sheet?

Sep 12
Does Neurocrine Biosciences (NASDAQ:NBIX) Have A Healthy Balance Sheet?

We Think Neurocrine Biosciences (NASDAQ:NBIX) Can Manage Its Debt With Ease

Jun 08
We Think Neurocrine Biosciences (NASDAQ:NBIX) Can Manage Its Debt With Ease

Neurocrine Biosciences (NASDAQ:NBIX) Has A Rock Solid Balance Sheet

Mar 08
Neurocrine Biosciences (NASDAQ:NBIX) Has A Rock Solid Balance Sheet

Does Neurocrine Biosciences (NASDAQ:NBIX) Have A Healthy Balance Sheet?

Dec 08
Does Neurocrine Biosciences (NASDAQ:NBIX) Have A Healthy Balance Sheet?

Neurocrine initiated Equal Weight at Wells Fargo despite upcoming catalysts

Sep 26

CEO報酬分析

Neurocrine Biosciences の収益と比較して、Kevin Gorman の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

US$370m

Dec 31 2023US$16mUS$946k

US$250m

Sep 30 2023n/an/a

US$191m

Jun 30 2023n/an/a

US$176m

Mar 31 2023n/an/a

US$64m

Dec 31 2022US$12mUS$860k

US$155m

Sep 30 2022n/an/a

US$58m

Jun 30 2022n/an/a

US$12m

Mar 31 2022n/an/a

US$71m

Dec 31 2021US$14mUS$825k

US$90m

Sep 30 2021n/an/a

US$445m

Jun 30 2021n/an/a

US$365m

Mar 31 2021n/an/a

US$402m

Dec 31 2020US$14mUS$775k

US$407m

Sep 30 2020n/an/a

US$93m

Jun 30 2020n/an/a

US$205m

Mar 31 2020n/an/a

US$177m

Dec 31 2019US$9mUS$725k

US$37m

Sep 30 2019n/an/a

US$21m

Jun 30 2019n/an/a

US$18m

Mar 31 2019n/an/a

-US$39m

Dec 31 2018US$9mUS$675k

US$21m

Sep 30 2018n/an/a

US$10m

Jun 30 2018n/an/a

-US$52m

Mar 31 2018n/an/a

-US$106m

Dec 31 2017US$8mUS$640k

-US$143m

報酬と市場: Kevinの 総報酬 ($USD 15.75M ) は、 US市場 ($USD 13.55M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Kevinの報酬は過去 1 年間で 20% 以上増加しました。


CEO(最高経営責任者

Kevin Gorman (66 yo)

16.4yrs

在職期間

US$15,750,812

報酬

Dr. Kevin C. Gorman, Ph D., has been Chief Executive Officer of Neurocrine Biosciences, Inc. since January 2008 and served as its President since January 2008. Dr. Gorman is a Founder of Neurocrine Bioscie...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Kevin Gorman
CEO & Director16.4yrsUS$15.75m0.51%
$ 70.1m
Matthew Abernethy
Chief Financial Officer6.6yrsUS$6.06m0.031%
$ 4.3m
Jude Onyia
Chief Scientific Officer2.6yrsUS$7.22m0.013%
$ 1.8m
Kyle Gano
Chief Business Development & Strategy Officer13.4yrsUS$5.99m0.13%
$ 18.4m
Eiry Roberts
Chief Medical Officer6.4yrsUS$5.87m0.024%
$ 3.2m
Jane Sorensen
Head of Investor Relationsno dataデータなしデータなし
Darin Lippoldt
Chief Legal Officer & Corporate Secretary9.7yrsUS$4.72m0.039%
$ 5.4m
Julie Cooke
Chief Human Resources Officer6.8yrsデータなし0.018%
$ 2.4m
Eric Benevich
Chief Commercial Officer9.1yrsUS$5.81m0.041%
$ 5.6m
David Boyer
Chief Corporate Affairs Officer4.8yrsデータなし0.0049%
$ 666.4k
Ingrid Delaet
Chief Regulatory Officer1.7yrsデータなし0.0075%
$ 1.0m
Christopher O'Brien
Exclusive Consultant6.4yrsUS$3.10mデータなし

6.6yrs

平均在職期間

58yo

平均年齢

経験豊富な経営陣: NBIXの経営陣は経験豊富で経験豊富です(平均在職期間は6.6年)。


取締役

名称ポジション在職期間報酬所有権
Kevin Gorman
CEO & Director16.4yrsUS$15.75m0.51%
$ 70.1m
Christine Poon
Independent Directorless than a yearUS$813.45k0%
$ 0
Richard Pops
Independent Director26.2yrsUS$492.04k0.031%
$ 4.3m
Stephen Sherwin
Independent Director25.2yrsUS$479.54k0.026%
$ 3.6m
William Rastetter
Independent Chairman of the Board14.3yrsUS$495.04k0.051%
$ 7.0m
Gary Lyons
Independent Director31.3yrsUS$460.11k0.12%
$ 16.2m
George Morrow
Independent Director8.7yrsUS$479.54k0.0042%
$ 571.8k
Shalini Sharp
Independent Director4.3yrsUS$497.11k0.00099%
$ 135.8k
Leslie Norwalk
Independent Director4.8yrsUS$475.11k0.00099%
$ 135.8k
Johanna Mercier
Independent Director3.2yrsUS$467.61k0.0021%
$ 286.6k

11.5yrs

平均在職期間

69yo

平均年齢

経験豊富なボード: NBIXの 取締役会 は経験豊富で 経験豊富 です ( 11.5年の平均在任期間)。